CCEL logo

Cryo-Cell International, Inc. (CCEL)

Profile

Full Name

Cryo-Cell International, Inc.

Ticker

NYSEAmerican: CCEL

Exchange

NYSE American

Sector

Healthcare

Industry

Medical Care Facilities

Country

United States

IPO

April 4, 1994

Indexes

Not included

Website

https://www.cryo-cell.com

Employees

82

Key Details

Price

$4.44(-1.77%)

Market cap

Last Dividend

$0.15

TTM Dividend yield

9.01%

Annual revenue

$31.99M(+2.05% YoY)

Annual EPS

$0.05(+104.39% YoY)

PE ratio

-

Next earnings date

Oct 15, 2025

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $4.44
    CCEL price is $4.44

    30-Day Relative Volume

    1.08
    CCEL 30-day relative volume is 1.08

    Price Performance

    Price Today change

    -1.77%
    CCEL price is down -1.77% today

    Price YTD change

    -40.08%
    CCEL price is down -40.08% since January 1st

    Price 1-year change

    -30.19%
    CCEL price is down -30.19% year-on-year

    Price 3-year change

    -36.57%
    CCEL price is down -36.57% over the past 3 years

    Price Range

    Price All-time high

    $14.16
    CCEL price is currently -68.64% below its historical high of $14.16

    Price 3-year low

    $2.69
    CCEL price is currently +65.06% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market cap

    $35.77M
    CCEL market capitalization is $35.77 million

    Market cap 3-year change

    -40.05%
    CCEL market capitalization is down -40.05% over the past 3 years

    Market cap All-time high

    $120.78M
    CCEL market capitalization is currently -70.38% below its historical high of $120.78 million

    Market cap sector rank

    28.36%
    CCEL market capitalization is higher than 28.36% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    -0.06%
    CCEL shares outstanding is down -0.06% year-on-year

    Shares Outstanding 3-Year Change

    -5.49%
    CCEL shares outstanding is down -5.49% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.16
    CCEL beta is 0.16

    200-day SMA

    $6.12
    CCEL price is currently -27.41% below its 200-day simple moving average

    50-day SMA

    $4.74
    CCEL price is currently -6.35% below its 50-day simple moving average

    RSI

    47.49
    CCEL 14-day relative strength index is 47.49

    Volume

    1.08
    CCEL 30-day relative volume is 1.08

    ATR

    $0.26
    CCEL average true range is $0.26

    10-day Historical Volatility

    45.56%
    CCEL 10-day historical volatility is 45.56%

    Dividend

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Events

    Last Paid Dividend

    $0.15
    CCEL last dividend was $0.15 per share, with an ex-dividend date of May 21, 2025

    Next Dividend

    -
    CCEL next dividend has not yet been announced

    Dividend per share

    Dividend per share

    $0.25
    CCEL annual dividend per share is $0.25

    Dividend per share Sector Rank

    12.79%
    CCEL annual dividend per share is higher than 12.79% of companies in Healthcare sector

    Dividend per share 1-Year Change

    -72.22%
    CCEL annual dividend per share is down -72.22% year-on-year

    Dividend per share 3-Year Change

    -
    CCEL annual dividend per share 3-year change is unknown

    Dividend yield

    Dividend yield

    5.63%
    CCEL annual dividend yield is 5.63%

    Dividend yield Sector Rank

    88.37%
    CCEL annual dividend yield is higher than 88.37% of companies in Healthcare sector

    Other

    Payout ratio

    502.49%
    CCEL annual payout ratio is 502.49%

    Dividends paid

    $2.02M
    CCEL annual dividends paid is $2.02 million

    Free cash flow

    $2.41M
    CCEL annual free cash flow is $2.41 million

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $31.99M
    CCEL annual revenue is $31.99 million

    Revenue Analysts estimate

    $31.91M
    CCEL annual revenue is currently +0.24% higher than the consensus analysts' forecast

    Revenue 1-year change

    +2.05%
    CCEL annual revenue is up +2.05% year-on-year

    Revenue Sector rank

    57.07%
    CCEL annual revenue is higher than 57.07% of companies in Healthcare sector

    EPS

    EPS

    $0.05
    CCEL annual earnings per share is $0.05

    EPS Analysts estimate

    $0.04
    CCEL annual earnings per share is currently +25.00% higher than the consensus analysts' forecast

    EPS 1-year change

    +104.39%
    CCEL annual earnings per share is up +104.39% year-on-year

    EPS Sector rank

    83.45%
    CCEL annual earnings per share is higher than 83.45% of companies in Healthcare sector

    Profit

    Gross profit

    $23.55M
    CCEL annual gross profit is $23.55 million

    Gross margin

    73.64%
    CCEL annual gross profit margin is 73.64%

    Operating profit

    $3.79M
    CCEL annual operating income is $3.79 million

    Operating margin

    11.85%
    CCEL annual operating profit margin is 11.85%

    Net income

    $402.10K
    CCEL annual net profit is $402.10 thousand

    Net margin

    1.26%
    CCEL annual net profit margin is 1.26%

    Expenses

    Total expenses

    $28.20M
    CCEL annual total expenses is $28.20 million

    Operating expenses

    $20.25M
    CCEL annual total operating expenses is $20.25 million

    Cost of goods sold

    $8.43M
    CCEL annual cost of goods sold is $8.43 million

    Selling, general & administrative expenses

    $18.52M
    CCEL annual SGA is $18.52 million

    Depreciation and amortization

    $1.02M
    CCEL annual depreciation & amortization is $1.02 million

    Interest expense

    $0.00
    CCEL annual interest expense is $0.00

    Income tax

    $2.40M
    CCEL annual income tax is $2.40 million

    EBIT & EBITDA

    EBIT

    $4.67M
    CCEL annual earnings before interest & taxes is $4.67 million

    EBITDA

    $5.69M
    CCEL annual EBITDA is $5.69 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total assets

    $64.68M
    CCEL annual total assets is $64.68 million

    Non current assets

    $52.12M
    CCEL annual long term assets is $52.12 million

    Current assets

    $12.55M
    CCEL annual total current assets is $12.55 million

    Cash and cash equivalents

    $561.00K
    CCEL annual cash & cash equivalents is $561.00 thousand

    Accounts receivable

    $7.31M
    CCEL annual accounts receivable is $7.31 million

    Inventory

    $657.70K
    CCEL annual inventory is $657.70 thousand

    Liabilities

    Total liabilities

    $77.89M
    CCEL annual total liabilities is $77.89 million

    Long term liabilities

    $56.29M
    CCEL annual total long term liabilities is $56.29 million

    Current liabilities

    $21.60M
    CCEL annual total current liabilities is $21.60 million

    Accounts payable

    $1.88M
    CCEL annual accounts payable is $1.88 million

    Debt

    Total debt

    $12.93M
    CCEL annual total debt is $12.93 million

    Total debt 1-year change

    +18.7%
    CCEL annual total debt is up +18.7% year-on-year

    Long term debt

    $8.82M
    CCEL annual long term debt is $8.82 million

    Short term debt

    $4.12M
    CCEL annual short term debt is $4.12 million

    Equity & Capital

    Shareholders equity

    -$13.22M
    CCEL annual stockholders equity is -$13.22 million

    Book value

    -$13.22M
    CCEL annual book value is -$13.22 million

    Retained earnings

    -$32.78M
    CCEL annual retained earnings is -$32.78 million

    Working capital

    -$9.04M
    CCEL annual working capital is -$9.04 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash from operations

    $6.01M
    CCEL annual cash flow from operations is $6.01 million

    Cash from operations 1-year change

    -32.61%
    CCEL annual cash flow from operations is down -32.61% year-on-year

    Cash from investing

    -$4.88M
    CCEL annual cash flow from investing activities is -$4.88 million

    Cash from investing 1-year change

    +40.12%
    CCEL annual cash flow from investing activities is up +40.12% year-on-year

    Cash from financing

    -$979.10K
    CCEL annual cash flow from financing activities is -$979.10 thousand

    Cash from financing 1-year change

    +52.77%
    CCEL annual cash flow from financing activities is up +52.77% year-on-year

    CAPEX

    CAPEX

    $3.60M
    CCEL annual capital expenditures is $3.60 million

    CAPEX 1-year change

    -52.82%
    CCEL annual capital expenditures is down -52.82% year-on-year

    Free Cash Flow

    Free cash flow

    $2.41M
    CCEL annual free cash flow is $2.41 million

    Free cash flow 1-year change

    +87.95%
    CCEL annual free cash flow is up +87.95% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross margin

    73.64%
    CCEL annual gross profit margin is 73.64%

    Operating margin

    11.85%
    CCEL annual operating profit margin is 11.85%

    Net margin

    1.26%
    CCEL annual net profit margin is 1.26%

    ROA & ROE

    ROA

    0.64%
    CCEL annual return on assets is 0.64%

    ROE

    -3.04%
    CCEL annual return on equity is -3.04%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE ratio

    -
    CCEL price to earnings ratio value is unknown

    PE ratio Sector rank

    -
    CCEL price to earnings ratio is unknown

    PB Ratio

    PB ratio

    -2.30
    CCEL price to book ratio is -2.30

    PB ratio Sector rank

    8.5%
    CCEL price to book ratio is higher than 8.5% of companies in Healthcare sector

    PS Ratio

    PS ratio

    1.12
    CCEL price to sales ratio is 1.12

    PS ratio Sector rank

    22.65%
    CCEL price to sales ratio is higher than 22.65% of companies in Healthcare sector

    Enterprise value

    Enterprise value

    $47.11M
    CCEL enterprise value is $47.11 million

    Enterprise value Sector rank

    38.72%
    CCEL enterprise value is higher than 38.72% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    8.84
    CCEL EV/EBITDA is 8.84

    EV/EBITDA Sector rank

    80.47%
    CCEL EV/EBITDA is higher than 80.47% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current ratio

    0.58
    CCEL annual current ratio is 0.58

    Quick ratio

    0.55
    CCEL annual quick ratio is 0.55

    Leverage

    Debt to equity

    -0.91
    CCEL annual debt to equity ratio is -0.91

    Interest coverage ratio

    -
    CCEL annual interest coverage ratio value is unknown

    Risk & Stability

    Piotroski F-Score

    5
    CCEL piotroski f-score is 5

    Altman Z-Score

    0.13
    CCEL altman z-score is 0.13

    Analyst ratings

    Recent major analysts updates

    Mar 4, 25 Maxim Group
    Buy
    Aug 29, 22 Maxim Group
    Buy

    Institutional Ownership

    Screeners with CCEL included

    US stocks
    Stocks below SMA 200
    Most recommended stocks
    Stocks below analysts price target
    Healthcare sector
    All stocks
    High-Yield Dividend Stocks
    Companies with buyback
    Best performing stocks last 15 years
    Top dividend stocks in sectors
    • What is the ticker symbol for Cryo-Cell International, Inc.?
    • Does Cryo-Cell International, Inc. pay dividends?
    • What sector is Cryo-Cell International, Inc. in?
    • What industry is Cryo-Cell International, Inc. in?
    • What country is Cryo-Cell International, Inc. based in?
    • When did Cryo-Cell International, Inc. go public?
    • Is Cryo-Cell International, Inc. in the S&P 500?
    • Is Cryo-Cell International, Inc. in the NASDAQ 100?
    • Is Cryo-Cell International, Inc. in the Dow Jones?
    • When was Cryo-Cell International, Inc.'s last earnings report?
    • When does Cryo-Cell International, Inc. report earnings?

    What is the ticker symbol for Cryo-Cell International, Inc.?

    The ticker symbol for Cryo-Cell International, Inc. is NYSEAmerican:CCEL

    Does Cryo-Cell International, Inc. pay dividends?

    Yes, Cryo-Cell International, Inc. pays dividends. The last payment was $0.15, with an ex-dividend date on May 21, 2025

    What sector is Cryo-Cell International, Inc. in?

    Cryo-Cell International, Inc. is in the Healthcare sector

    What industry is Cryo-Cell International, Inc. in?

    Cryo-Cell International, Inc. is in the Medical Care Facilities industry

    What country is Cryo-Cell International, Inc. based in?

    Cryo-Cell International, Inc. is headquartered in United States

    When did Cryo-Cell International, Inc. go public?

    Cryo-Cell International, Inc.'s initial public offering (IPO) was on April 4, 1994

    Is Cryo-Cell International, Inc. in the S&P 500?

    No, Cryo-Cell International, Inc. is not included in the S&P 500 index

    Is Cryo-Cell International, Inc. in the NASDAQ 100?

    No, Cryo-Cell International, Inc. is not included in the NASDAQ 100 index

    Is Cryo-Cell International, Inc. in the Dow Jones?

    No, Cryo-Cell International, Inc. is not included in the Dow Jones index

    When was Cryo-Cell International, Inc.'s last earnings report?

    Cryo-Cell International, Inc.'s most recent earnings report was on July 15, 2025

    When does Cryo-Cell International, Inc. report earnings?

    The next expected earnings date for Cryo-Cell International, Inc. is October 15, 2025
    On this page